PharmaCorp Rx, Inc. (PCRX.V)
0.435
+0.01
(+2.35%)
CAD |
TSXV |
Mar 06, 16:00
PharmaCorp Rx Cash from Investing (TTM) : -26.19M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| High Tide, Inc. | -22.29M |
| Arch Biopartners, Inc. | 0.00 |
| Biocure Technology, Inc. | 0.00 |
| Resverlogix Corp. | -0.7665M |
| Microbix Biosystems, Inc. | -0.7646M |